Gyre Therapeutics
GYRE
GYRE
49 hedge funds and large institutions have $75.1M invested in Gyre Therapeutics in 2015 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 12 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
70% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 10
Holders
49
Holding in Top 10
2
Calls
$290K
Puts
$9K
Top Buyers
| 1 | +$1.39M | |
| 2 | +$357K | |
| 3 | +$281K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$250K |
| 5 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
+$42K |
Top Sellers
| 1 | -$446K | |
| 2 | -$361K | |
| 3 | -$342K | |
| 4 |
NCCM
Nine Chapters Capital Management
Short Hills,
New Jersey
|
-$119K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$107K |